跳至主要内容
临床试验/IRCT2014020316348N2
IRCT2014020316348N2已完成未知

carnitine effect in the treatment of non alcoholic fatty liver disease in typ 2 diabetic patients and comparision with placebo

Gastroentrology Recerch Center, Ahwaz Jundishapur Medical School0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
14 years 至 90 years(—)
性别
All

入选标准

  • Known case of diabetic type2 ? serum level of alanin aminotranspherase and aspartat aminotranspherase more than 2time of normal? and high level of triglicirid and cholestrol level ? ultrasonograghy evidences of fatty live.
  • Exclusion criteria: any causes of increasing liver enzymes such as viral infections? hemochromatosis ?alfa 1 anti tripsin dificiency?Wilson’s disease? autoimmune diseases? drinking (20 and 10 grams per day for men and women, respectively)

排除标准

  • 未提供

研究者

发起方
Gastroentrology Recerch Center, Ahwaz Jundishapur Medical School

相似试验

carnitine effect in diabetic fatty liver disease | 临床试验